Ocrevus® (Ocrelizumab) IV Infusion

Disease-Modifying Treatment for Relapsing and Primary Progressive Multiple Sclerosis

Clearwell Infusion Centers provides professional administration of Ocrevus (ocrelizumab) for patients with multiple sclerosis (MS). Our Miami center offers private infusion suites, low patient-to-nurse ratios, and personalized care in a comfortable, outpatient setting.

What Is Ocrevus?

Ocrevus® (ocrelizumab) is an FDA-approved monoclonal antibody used to treat adults with:

• Relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS
• Primary progressive multiple sclerosis (PPMS)

Ocrevus works by targeting CD20-positive B cells, which are believed to play a role in the autoimmune process that damages the central nervous system in MS. By reducing B cells, Ocrevus slows disease progression and reduces relapse rates.

It is administered via IV infusion every 6 months after two initial loading doses.

Learn more at the official Ocrevus website.

Who Is Ocrevus For?

Ocrevus is prescribed for adults with:

• Active relapsing forms of MS
• Primary progressive MS (PPMS)
• Evidence of inflammatory disease activity on MRI or clinical symptoms

Your neurologist will determine whether Ocrevus is the right fit based on disease course, MRI findings, and treatment history.

Ocrevus Side Effects

Ocrevus is generally well tolerated, but like all immunosuppressive medications, it may carry some risks. Common side effects include:

• Infusion-related reactions (fever, chills, rash, nausea)
• Upper respiratory tract infections
• Headache
• Fatigue
• Back pain

Rare but serious risks include infections, including hepatitis B reactivation, and a potential increased risk of malignancy. Patients are pre-medicated before each infusion and monitored closely throughout.

For full safety information, visit the Ocrevus safety guide.

Why Choose Clearwell for Your Ocrevus Infusion?

At Clearwell Infusion Centers, we provide a comfortable, supportive environment for patients managing chronic neurologic conditions like MS. When you receive Ocrevus at Clearwell, you benefit from:

• Private treatment suites with spa-like amenities
• Low patient-to-nurse ratio for attentive care
• Flexible appointment times, including weekends and evenings
• Comprehensive insurance coordination, including prior authorizations and benefits checks
• ACHC-accredited facility and safety standards
• Close coordination with your prescribing provider and care team

Infusions typically last 2.5 to 3.5 hours, depending on the dose and tolerance.

Getting Started with Ocrevus Treatment

If your neurologist has prescribed Ocrevus, Clearwell will coordinate your infusion therapy and handle all insurance approvals, scheduling, and pre-infusion requirements.

Questions? Call us at 305‑306‑7147 or email contact@clearwellinfusion.com.

Referring Providers: Partner with Clearwell Infusion Centers

Clearwell Infusion Centers partners with neurologists and MS specialists to deliver Ocrevus in a safe, efficient outpatient setting with high patient satisfaction.

Why refer your patients to Clearwell?

• Fast referral and scheduling turnaround
• Experienced clinical staff familiar with MS care protocols
• Timely documentation and follow-up communication
• Adherence to REMS and FDA guidelines
• ACHC-accredited facility with strong infection control standards

To refer a patient for Ocrevus infusion in Miami, contact our provider team at referrals@clearwellinfusion.com or call 305‑306‑7147.

Looking to start your Ocrevus treatment at Clearwell Infusion Centers?

Fill out the form below and a member of our team will contact you